Previously we have shown that transforming growth factor b (TGF b) 1, basic fibroblast growth factor (FGF), and platelet-derived growth factor (PDGF) BB inhibit the synthesis of insulin-like growth factor (IGF) II, but their effects on IGF binding protein (IGFBP)-6 in osteoblast cultures are not kno
Prognostic significance of insulin-like growth factor II mRNA-binding protein 3 expression in gastric adenocarcinoma
β Scribed by Y.-M. Jeng; T.-H. Wang; S.-H. Lu; R.-H. Yuan; H.-C. Hsu
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 262 KB
- Volume
- 96
- Category
- Article
- ISSN
- 0007-1323
- DOI
- 10.1002/bjs.6438
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Background
Insulin-like growth factor II mRNA-binding protein (IMP) 3 is expressed in embryonic tissues and multiple cancers. The aim was to establish the prognostic value of IMP-3 expression in gastric adenocarcinoma.
Methods
IMP-3 expression in resected gastric adenocarcinomas was analysed by immunohistochemistry.
Results
IMP-3 was expressed in 183 (58Β·1 per cent) of 315 tumours. Expression was associated with older age (P < 0Β·001), larger tumour size (P = 0Β·009), deep tumour invasion (P < 0Β·001) and lymph node metastasis (P < 0Β·001). IMP-3-positive tumours were associated with poorer 5-year survival than negative tumours at all stages (stage I, 82 versus 97 per cent; stage II, 55 versus 78 per cent; stage III and IV, 11 versus 25 per cent; P = 0Β·005, P = 0Β·033 and P = 0Β·036 respectively). Multivariable analysis identified IMP-3 (hazard ratio (HR) 1Β·93), depth of tumour invasion (HR 3Β·69, 9Β·77 and 10Β·69 for pathological tumour stage (pT) 2, pT3 and pT4 respectively versus pT1), and lymph node metastasis (HR 1Β·57, 3Β·29 and 3Β·40 for pathological node stage (pN) 1, pN2 and pN3 respectively versus pN0) as independent prognostic factors.
Conclusion
IMP-3 expression correlates with the metastatic potential of gastric adenocarcinoma and is an independent prognostic factor.
π SIMILAR VOLUMES
Insulin-like growth factors, IGF-I and IGF-II, are potent regulators of oligodendrocyte development. Most of the IGF present in vivo is bound to members of a family of six high-affinity IGF-binding proteins (IGFBPs), which can either potentiate or inhibit IGF action, depending on other conditions. A
Insulin-like growth factor-II (IGF-II) is an autocrine modulator of epiphyseal chondrogenesis in the fetus. The cellular availability of IGFs are influenced by the IGF-binding proteins (IGFBPs). In this study, we investigated the control of expression and release of IGFBPs from isolated epiphyseal g
Insulin-like growth factor-I (IGF-I) is essential for normal epidermal homeostasis; however, the role of IGF binding proteins (IGFBPs), regulators of IGF action, remains unclear. Here we examine the regulation of human keratinocyte-produced IGFBPs by epidermal growth factor (EGF), transforming growt